Neurointervention.  2021 Jul;16(2):141-148. 10.5469/neuroint.2021.00150.

Impact of Intravenous Aspirin Administration on Ventriculostomy-Associated Hemorrhage in Coiled Acute Subarachnoid Hemorrhage Patients

Affiliations
  • 1Department of Neuroradiology, North Bristol NHS Trust, Bristol, UK
  • 2Department of Neurosurgery, North Bristol NHS Trust, Bristol, UK

Abstract

Purpose
Aspirin has beneficial effects on coiling, even in acute subarachnoid hemorrhage, but there is also a perceived risk of increased bleeding and, importantly, a concern regarding ventriculostomy-associated hemorrhage (VAH) in those with complicating hydrocephalus. We aimed to assess the rate and extent of VAH in patients specifically treated with procedural intravenous aspirin during endovascular coiling of ruptured intracranial aneurysms.
Materials and Methods
This was a single neurovascular center retrospective observational study of consecutive patients treated over a three-year period. The rate of VAH assessed using computed tomography and clinical outcomes were compared in patients receiving intraprocedural intravenous aspirin loading (n=90) versus those that did not receive the drug (n=40).
Results
There was a significantly elevated rate of VAH in patients receiving intravenous aspirin (30% vs. 2.5%, odds ratio 16.7 [95% confidence interval: 2.2–128.0], P<0.0001). The majority of VAH was <10 mm in size (70%) with the largest bleed measuring 20 mm. No hematoma required surgical evacuation. No difference in favorable outcome at discharge was demonstrated. There was no difference in mortality between the 2 groups.
Conclusion
Loading with intravenous aspirin during endovascular treatment of ruptured intracranial aneurysms significantly increases the risk of VAH, but most are small with minimal impact on clinical outcome at discharge. Intravenous aspirin should probably be reserved for selected cases but should not be withheld based on risk of VAH.

Keyword

Aneurysm; Aspirin; External ventricular drain; Ventriculostomy; Antiplatelet; Subarachnoid haemorrhage

Figure

  • Fig. 1. Characteristic ventriculostomy-associated hemorrhage (VAH). (A) A typical <1 cm hematoma that accounted for the vast majority of VAH. (B) A 13 mm hematoma typical of the larger bleeds seen in the study. (C) The largest hematoma encountered in this study measuring 20 mm in the longest dimension.

  • Fig. 2. Summary of patient selection.


Reference

1. Edwards NJ, Jones WH, Sanzgiri A, Corona J, Dannenbaum M, Chen PR. Antiplatelet therapy for the prevention of peri-coiling thromboembolism in high-risk patients with ruptured intracranial aneurysms. J Neurosurg. 2017; 127:1326–1332.
Article
2. Ries T, Buhk JH, Kucinski T, Goebell E, Grzyska U, Zeumer H, et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke. 2006; 37:1816–1821.
Article
3. van den Bergh WM; MASH Study Group, Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, van Gijn J, et al. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study. Stroke. 2006; 37:2326–2330.
4. Cagnazzo F, Derraz I, Lefevre PH, Gascou G, Dargazanli C, Riquelme C, et al. Antiplatelet therapy in patients with aneurysmal SAH: impact on delayed cerebral ischemia and clinical outcome. A meta-analysis. AJNR Am J Neuroradiol. 2019; 40:1201–1206.
Article
5. Ditz C, Machner B, Schacht H, Neumann A, Schramm P, Tronnier VM, et al. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience. [published online ahead of print Jan 25, 2021] Neurosurg Rev 2021.
6. Parkhutik V, Lago A, Tembl JI, Rubio C, Fuset MP, Vallés J, et al. Influence of COX-inhibiting analgesics on the platelet function of patients with subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2012; 21:755–759.
Article
7. Meves SH, Neubauer H, Overbeck U, Endres HG. Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry. BMC Res Notes. 2011; 4:106.
Article
8. Bechan RS, Sprengers ME, Majoie CB, Peluso JP, Sluzewski M, van Rooij WJ. Stent-assisted coil embolization of intracranial aneurysms: complications in acutely ruptured versus unruptured aneurysms. AJNR Am J Neuroradiol. 2016; 37:502–507.
Article
9. Cagnazzo F, Di Carlo DT, Petrella G, Perrini P. Ventriculostomy-related hemorrhage in patients on antiplatelet therapy for endovascular treatment of acutely ruptured intracranial aneurysms. A meta-analysis. Neurosurg Rev. 2020; 43:397–406.
Article
10. Gardner PA, Engh J, Atteberry D, Moossy JJ. Hemorrhage rates after external ventricular drain placement. J Neurosurg. 2009; 110:1021–1025.
Article
11. Maniker AH, Vaynman AY, Karimi RJ, Sabit AO, Holland B. Hemorrhagic complications of external ventricular drainage. Neurosurgery. 2006; 59(4 Suppl 2):ONS41–424; discussion ONS424-425.
Article
12. Sussman ES, Kellner CP, Nelson E, McDowell MM, Bruce SS, Bruce RA, et al. Hemorrhagic complications of ventriculostomy: incidence and predictors in patients with intracerebral hemorrhage. J Neurosurg. 2014; 120:931–936.
Article
13. Müller A, Mould WA, Freeman WD, McBee N, Lane K, Dlugash R, CLEAR investigators, et al. The incidence of catheter tract hemorrhage and catheter placement accuracy in the clear III trial. Neurocrit Care. 2018; 29:23–32.
Article
14. Hudson JS, Prout BS, Nagahama Y, Nakagawa D, Guerrero WR, Zanaty M, et al. External ventricular drain and hemorrhage in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy: a retrospective cohort study. Neurosurgery. 2019; 84:479–484.
Article
15. Qin G, Pang G, Zhong S, Chen H, Tang X, Lan S. Increased risk of ventriculostomy-associated hemorrhage in patients treated with antiplatelet agents for stent-assisted coiling of ruptured intracranial aneurysms. Br J Neurosurg. 2021; 35:270–274.
Article
16. Bruder M, Schuss P, Konczalla J, El-Fiki A, Lescher S, Vatter H, et al. Ventriculostomy-related hemorrhage after treatment of acutely ruptured aneurysms: the influence of anticoagulation and antiplatelet treatment. World Neurosurg. 2015; 84:1653–1659.
Article
17. Majmundar N, Sarris C, Shastri D, Doran J, Gandhi C, Assina R. Hemorrhagic complications of external ventriculostomy in the aspirin and P2Y12 response assay era. World Neurosurg. 2019; 122:e961–e968.
Article
18. van den Bergh WM, Algra A, Rinkel GJ; MASH Study Group. Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion. J Neurol. 2009; 256:213–216.
Full Text Links
  • NI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr